ÂÜÀòÂÒÂ×

Daniel Schulz-Jander is a seasoned professional in the field of analytical chemistry and biopharmaceutical development, currently serving as Sr. Director at QPS Netherlands B.V. since February 2022. Prior to this role, Daniel held positions including Site & Lab Head for Bioanalytical and Biologics Services at Frontage Laboratories, Inc. and distinguished scientist at Medtronic, where responsibilities spanned strategic leadership for drug combination product development, analytical chemistry oversight, and regulatory compliance. Daniel's extensive experience includes roles such as research director, technical fellow, and principal scientist across multiple organizations, emphasizing the development and characterization of drug delivery systems and bioanalytical capabilities. Educational credentials include a Ph.D. in Analytical Chemistry from the Technical University of Munich, along with postdoctoral research in small molecule metabolism at the University of California, Berkeley.